RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 151 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,686 | -16.8% | 21,103 | +0.6% | 0.00% | – |
| Q2 2023 | $27,264 | -2.3% | 20,972 | 0.0% | 0.00% | – |
| Q1 2023 | $27,893 | -89.6% | 20,972 | -73.4% | 0.00% | – |
| Q1 2021 | $269,000 | -60.4% | 78,823 | -59.0% | 0.00% | -100.0% |
| Q4 2020 | $679,000 | +46.0% | 192,447 | -0.0% | 0.00% | 0.0% |
| Q3 2020 | $465,000 | +17.4% | 192,450 | -11.1% | 0.00% | 0.0% |
| Q2 2020 | $396,000 | +63.0% | 216,582 | +38.8% | 0.00% | 0.0% |
| Q1 2020 | $243,000 | -27.7% | 156,006 | +0.4% | 0.00% | 0.0% |
| Q4 2019 | $336,000 | +4.0% | 155,392 | -10.0% | 0.00% | 0.0% |
| Q3 2019 | $323,000 | +1142.3% | 172,697 | +1617.5% | 0.00% | – |
| Q2 2019 | $26,000 | -10.3% | 10,055 | -9.4% | 0.00% | – |
| Q1 2019 | $29,000 | -29.3% | 11,098 | -35.6% | 0.00% | – |
| Q4 2016 | $41,000 | – | 17,229 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 8,350,000 | $28,557,000 | 5.86% |
| Ion Asset Management Ltd. | 3,632,132 | $12,422,000 | 1.43% |
| CM Management, LLC | 500,000 | $1,710,000 | 1.27% |
| SECTOR GAMMA AS | 1,530,490 | $5,234,000 | 0.96% |
| Rhenman & Partners Asset Management AB | 1,520,000 | $5,198,000 | 0.36% |
| Rock Springs Capital Management LP | 4,742,000 | $16,218,000 | 0.35% |
| Telemetry Investments, L.L.C. | 90,000 | $308,000 | 0.35% |
| DAFNA Capital Management LLC | 275,500 | $942,000 | 0.22% |
| KELLEHER FINANCIAL ADVISORS | 100,000 | $342,000 | 0.22% |
| Virtus ETF Advisers LLC | 91,971 | $315,000 | 0.13% |